Heterogeneity in multiple sclerosis: Scratching the surface of a complex disease

Autoimmune Diseases

Volumn 1, Issue 1, 2011, Pages

  Disanto, Giulio ^a,b   Berlanga, Antonio J ^a,c   Handel, Adam E ^a,b   Para, Andrea E ^a,b   Burrell, Amy M ^a,b   Fries, Anastasia ^a   Handunnetthi, Lahiru ^a,b   De Luca, Gabriele C ^a,b   Morahan, Julia M ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BIOLOGICAL MARKER; C LECTIN DOMAIN A; CD226 ANTIGEN; CD40 ANTIGEN; CD6 ANTIGEN; ECOTROPIC VIRAL INTEGRATION SITE 5 PROTEIN; FOCAL ADHESION KINASE 1; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DRB1 ANTIGEN; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR ALPHA; KINESIN 1; KINESIN FAMILY MEMBER 1B; LECTIN; PROTEIN; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ALLELE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL TYPE; CLINICAL FEATURE; DIAGNOSTIC TEST; ENVIRONMENTAL FACTOR; GENE LOCUS; GENETIC EPISTASIS; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEREDITY; HUMAN; IMMUNOPATHOLOGY; IMMUNOPHENOTYPING; MARBURG HEMORRHAGIC FEVER; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; OUTCOME ASSESSMENT; PATHOGENESIS; PERSONALIZED MEDICINE; PRIORITY JOURNAL; REVIEW;

EID: 84877654431     PISSN: None     EISSN: 20900430     Source Type: Journal    
DOI: 10.4061/2011/932351     Document Type: Review

References (118)

1. Noseworthy J. H., Lucchinetti C., Rodriguez M., Weinshenker B. G., Multiple sclerosis The New England Journal of Medicine 2000 343 13 938 952
2. Ramagopalan S. V., Dobson R., Meier U. C., Giovannoni G., Multiple sclerosis: risk factors, prodromes, and potential causal pathways The Lancet Neurology 2010 9 7 727 739
3. Freedman M. S., Thompson E. J., Deisenhammer F., Giovannoni G., Grimsley G., Keir G., hman S., Racke M. K., Sharief M., Sindic C. J. M., Sellebjerg F., Tourtellotte W. W., Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement Archives of Neurology 2005 62 6 865 870 (Pubitemid 40973448)
4. Rejdak K., Jackson S., Giovannoni G., Multiple sclerosis: a practical overview for clinicians British Medical Bulletin 2010 95 1 79 104
5. Scalfari A., Neuhaus A., Degenhardt A., Rice G. P., Muraro P. A., Daumer M., Ebers G. C., The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability Brain 2010 133 7 1914 1929
6. Compston A., Coles A., Multiple sclerosis The Lancet 2002 359 9313 1221 1231 (Pubitemid 34304266)
7. Lucchinetti C., Brck W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H., Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination Annals of Neurology 2000 47 6 707 717 (Pubitemid 30390191)
8. Koch M., Kingwell E., Rieckmann P., Tremlett H., The natural history of primary progressive multiple sclerosis Neurology 2009 73 23 1996 2002
9. Confavreux C., Vukusic S., Natural history of multiple sclerosis: a unifying concept Brain 2006 129 3 606 616 (Pubitemid 43278223)
10. Cottrell D. A., Kremenchutzky M., Rice G. P. A., Hader W., Baskerville J., Ebers G. C., The natural history of multiple sclerosis: a geographically based study. 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis Brain 1999 122 4 641 647 (Pubitemid 29158772)
11. Confavreux C., Vukusic S., Moreau T., Adeleine P., Relapses and progression of disability in multiple sclerosis The New England Journal of Medicine 2000 343 20 1430 1438
12. Pittock S. J., McClelland R. L., Mayr W. T., Jorgensen N. W., Weinshenker B. G., Noseworthy J., Rodriguez M., Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study Annals of Neurology 2004 56 2 303 306 (Pubitemid 39037929)
13. Kira J.-I., Neuromyelitis optica and Asian phenotype of multiple sclerosis Annals of the New York Academy of Sciences 2008 1142 58 71
14. Lennon V. A., Kryzer T. J., Pittock S. J., Verkman A. S., Hinson S. R., IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel Journal of Experimental Medicine 2005 202 4 473 477 (Pubitemid 41186945)
15. Simon J. H., Kleinschmidt-DeMasters B. K., Variants of multiple sclerosis Neuroimaging Clinics of North America 2008 18 4 703 716
16. Hu W., Lucchinetti C. F., The pathological spectrum of CNS inflammatory demyelinating diseases Seminars in Immunopathology 2009 31 4 439 453
17. Jersild C., Fog T., Hansen G. S., Thomsen M., Svejgaard A., Dupont B., Histocompatibility determinants in multiple sclerosis, with special reference to clinical course The Lancet 1973 2 7840 1221 1225
18. Fogdell A., Hillert J., Sachs C., Olerup O., The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB50101 allele Tissue Antigens 1995 46 4 333 336
19. Caillier S. J., Briggs F., Cree B. A. C., Baranzini S. E., Fernandez-Via M., Ramsay P. P., Khan O., Royal W. III, Hauser S. L., Barcellos L. F., Oksenberg J. R., Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis Journal of Immunology 2008 181 8 5473 5480
20. Ramagopa S. V., Ebers G. C., Multiple sclerosis: major histocompatibility complexity and antigen presentation Genome Medicine 2009 1 11 105
21. Oksenberg J. R., Barcellos L. F., Cree B. A. C., Baranzini S. E., Bugawan T. L., Khan O., Lincoln R. R., Swerdlin A., Mignot E., Lin L., Goodin D., Erlich H. A., Schmidt S., Thomson G., Reich D. E., Pericak-Vance M. A., Haines J. L., Hauser S. L., Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans American Journal of Human Genetics 2004 74 1 160 167 (Pubitemid 38085247)
22. Ballerini C., Guerini F. R., Rombol G., Rosati E., Massacesi L., Ferrante P., Caputo D., Talamanca L. F., Naldi P., Liguori M., Alizadeh M., Momigliano-Richiardi P., D'Alfonso S., HLA-multiple sclerosis association in Continental Italy and correlation with disease prevalence in Europe Journal of Neuroimmunology 2004 150 1-2 178 185 (Pubitemid 38481662)
23. Kwon O. J., Karni A., Israel S., Brautbar C., Amar A., Meiner Z., Abramsky O., Karussis D., HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews Archives of Neurology 1999 56 5 555 560 (Pubitemid 29218150)
24. Masterman T., Ligers A., Olsson T., Andersson M., Olerup O., Hillert J., HLA-DR15 is associated with lower age at onset in multiple sclerosis Annals of Neurology 2000 48 2 211 219 (Pubitemid 30617040)
25. Barcellos L. F., Sawcer S., Ramsay P. P., Baranzini S. E., Thomson G., Briggs F., Cree B. C. A., Begovich A. B., Villoslada P., Montalban X., Uccelli A., Savettieri G., Lincoln R. R., DeLoa C., Haines J. L., Pericak-Vance M. A., Compston A., Hauser S. L., Oksenberg J. R., Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis Human Molecular Genetics 2006 15 18 2813 2824 (Pubitemid 44400408)
26. Ramagopalan S. V., Morris A. P., Dyment D. A., Herrera B. M., DeLuca G. C., Lincoln M. R., Orton S. M., Chao M. J., Sadovnick A. D., Ebers G. C., The inheritance of resistance alleles in multiple sclerosis PLoS Genetics 2007 3 9 1607 1613 (Pubitemid 47510254)
27. Dyment D. A., Herrera B. M., Cader M. Z., Willer C. J., Lincoln M. R., Sadovnick A. D., Risch N., Ebers G. C., Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance Human Molecular Genetics 2005 14 14 2019 2026 (Pubitemid 41418037)
28. Matsuoka T., Matsushita T., Osoegawa M., Kawano Y., Minohara M., Mihara F., Nishimura Y., Ohyagi Y., Kira J.-I., Association of the HLA-DRB1 alleles with characteristic MRI features of Asian multiple sclerosis Multiple Sclerosis 2008 14 9 1181 1190
29. Marrosu M. G., Murru R., Murru M. R., Costa G., Zavattari P., Whalen M., Cocco E., Mancosu C., Schirru L., Solla E., Fadda E., Melis C., Porru I., Rolesu M., Cucca F., Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia Human Molecular Genetics 2001 10 25 2907 2916 (Pubitemid 34030922)
30. Pina M. A., Ara J. R., Lasierra P., Modrego P. J., Larrad L., Study of HLA as a predisposing factor and its possible influence on the outcome of multiple sclerosis in the sanitary district of Calatayud, northern Spain Neuroepidemiology 1999 18 4 203 209 (Pubitemid 29284081)
31. Bergamaschi L., Leone M. A., Fasano M. E., Guerini F. R., Ferrante D., Bolognesi E., Barizzone N., Corrado L., Naldi P., Agliardi C., Dametto E., Salvetti M., Visconti A., Galimberti D., Scarpini E., Vercellino M., Bergamaschi R., Monaco F., Caputo D., Momigliano-Richiardi P., D'Alfonso S., HLA-class I markers and multiple sclerosis susceptibility in the Italian population Genes and Immunity 2010 11 2 173 180
32. Yeo T. W., De Jager P. L., Gregory S. G., Barcellos L. F., Walton A., Goris A., Fenoglio C., Ban M., Taylor C. J., Goodman R. S., Walsh E., Wolfish C. S., Horton R., Traherne J., Beck S., Trowsdale J., Caillier S. J., Ivinson A. J., Green T., Pobywajlo S., Lander E. S., Pericak-Vance M. A., Haines J. L., Daly M. J., Oksenberg J. R., Hauser S. L., Compston A., Hafler D. A., Rioux J. D., Sawcer S., A second major histocompatibility complex susceptibility locus for multiple sclerosis Annals of Neurology 2007 61 3 228 236 (Pubitemid 46557347)
33. Brynedal B., Duvefelt K., Jonasdottir G., Roos I. M., kesson E., Palmgren J., Hillert J., HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis PLoS ONE 2007 2 7
34. Rioux J. D., Goyette P., Vyse T. J., Hammarstrm L., Fernando M. M. A., Green T., De Jager P. L., Foisy S., Wang J., De Bakker P. I.W., Leslie S., McVean G., Padyukov L., Alfredsson L., Annese V., Hafler D. A., Pan-Hammarstrm Q., Matell R., Sawcer S. J., Compston A. D., Cree B. A.C., Mirel D. B., Daly M. J., Behrens T. W., Klareskog L., Gregersen P. K., Oksenberg J. R., Hauser S. L., Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases Proceedings of the National Academy of Sciences of the United States of America 2009 106 44 18680 18685
35. Lincoln M. R., Ramagopalan S. V., Chao M. J., Herrera B. M., Deluca G. C., Orton S.-M., Dyment D. A., Sadovnick A. D., Ebers G. C., Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility Proceedings of the National Academy of Sciences of the United States of America 2009 106 18 7542 7547
36. Chao M. J., Ramagopalan S. V., Herrera B. M., Lincoln M. R., Dyment D. A., Sadovnick A. D., Ebers G. C., Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex Human Molecular Genetics 2009 18 2 261 266
37. D'Netto M. J., Ward H., Morrison K. M., Ramagopalan S. V., Dyment D. A., Deluca G. C., Handunnetthi L., Sadovnick A. D., Ebers G. C., Risk alleles for multiple sclerosis in multiplex families Neurology 2009 72 23 1984 1988
38. Hafler D. A., Compston A., Sawcer S., Lander E. S., Daly M. J., De Jager P. L., De Bakker P. I. W., Gabriel S. B., Mirel D. B., Ivinson A. J., Pericak-Vance M. A., Gregory S. G., Rioux J. D., McCauley J. L., Haines J. L., Barcellos L. F., Cree B., Oksenberg J. R., Hauser S. L., Risk alleles for multiple sclerosis identified by a genomewide study The New England Journal of Medicine 2007 357 9 851 862 (Pubitemid 47347319)
39. Lundmark F., Duvefelt K., Iacobaeus E., Kockum I., Wallstrm E., Khademi M., Oturai A., Ryder L. P., Saarela J., Harbo H. F., Celius E. G., Salter H., Olsson T., Hillert J., Variation in interleukin 7 receptor chain (IL7R) influences risk of multiple sclerosis Nature Genetics 2007 39 9 1108 1113 (Pubitemid 47340654)
40. Weber F., Fontaine B., Cournu-Rebeix I., Kroner A., Knop M., Lutz S., Mller-Sarnowski F., Uhr M., Bettecken T., Kohli M., Ripke S., Ising M., Rieckmann P., Brassat D., Semana G., Babron M.-C., Mrejen S., Gout C., Lyon-Caen O., Yaouanq J., Edan G., Clanet M., Holsboer F., Clerget-Darpoux F., Mller-Myhsok B., IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations Genes and Immunity 2008 9 3 259 263 (Pubitemid 351584192)
41. Gregory S. G., Schmidt S., Seth P., Oksenberg J. R., Hart J., Prokop A., Caillier S. J., Ban M., Goris A., Barcellos L. F., Lincoln R., McCauley J. L., Sawcer S. J., Compston D. A. S., Dubois B., Hauser S. L., Garcia-Blanco M. A., Pericak-Vance M. A., Haines J. L., Interleukin 7 receptor chain (IL7R) shows allelic and functional association with multiple sclerosis Nature Genetics 2007 39 9 1083 1091 (Pubitemid 47340652)
42. Refining genetic associations in multiple sclerosis The Lancet Neurology 2008 7 7 567 569
43. De Jager P. L., Baecher-Allan C., Maier L. M., Arthur A. T., Ottoboni L., Barcellos L., McCauley J. L., Sawcer S., Goris A., Saarela J., Yelensky R., Price A., Leppa V., Patterson N., De Bakker P. I. W., Tran D., Aubin C., Pobywajlo S., Rossin E., Hu X., Ashley C. W., Choy E., Rioux J. D., Pericak-Vance M. A., Ivinson A., Booth D. R., Stewart G. J., Palotie A., Peltonen L., Dubois B., Haines J. L., Weiner H. L., Compston A., Hauser S. L., Daly M. J., Reich D., Oksenberg J. R., Hafler D. A., The role of the CD58 locus in multiple sclerosis Proceedings of the National Academy of Sciences of the United States of America 2009 106 13 5264 5269
44. Ban M., Goris A., Lorentzen. R., Baker A., Mihalova T., Ingram G., Booth D. R., Heard R. N., Stewart G. J., Bogaert E., Dubois B., Harbo H. F., Celius E. G., Spurkland A., Strange R., Hawkins C., Robertson N. P., Dudbridge F., Wason J., De Jager P. L., Hafler D., Rioux J. D., Ivinson A. J., McCauley J. L., Pericak-Vance M., Oksenberg J. R., Hauser S. L., Sexton D., Haines J., Sawcer S., Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor European Journal of Human Genetics 2009 17 10 1309 1313
45. Bahlo M., Booth D. R., S. A. B., Brown M. A., Foote S. J., Griffiths L. R., Kilpatrick T. J., Lechner-Scott J., Moscato P., Perreau V. M., Rubio J. P., Scott R. J., Stankovich J., Stewart G. J., Taylor B. V., Wiley J., Clarke G., Cox M. B., Csurhes P. A., Danoy P., Drysdale K., Field J., Greer J. M., Guru P., Hadler J., McMorran B. J., Jensen C. J., Johnson L. J., McCallum R., Merriman M., Merriman T., Pryce K., Tajouri L., Wilkins E. J., Browning B. L., Browning S. R., Perera D., Broadley S., Butzkueven H., Carroll W. M., Chapman C., Kermode A. G., Marriott M., Mason D., Heard R. N., Pender M. P., Slee M., Tubridy N., Willoughby E., Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 Nature Genetics 2009 41 7 824 828
46. Burton P. R., Clayton D. G., Cardon L. R., Craddock N., Deloukas P., Duncanson A., Kwiatkowski D. P., McCarthy M. I., Ouwehand W. H., Samani N. J., Todd J. A., Donnelly P., Barrett J. C., Davison D., Easton D., Evans D. M., Leung H.-T., Marchini J. L., Morris A. P., Spencer C. C. A., Tobin M. D., Attwood A. P., Boorman J. P., Cant B., Everson U., Hussey J. M., Jolley J. D., Knight A. S., Koch K., Meech E., Nutland S., Prowse C. V., Stevens H. E., Taylor N. C., Walters G. R., Walker N. M., Watkins N. A., Winzer T., Jones R. W., McArdle W. L., Ring S. M., Strachan D. P., Pembrey M., Breen G., Clair D. ST., Caesar S., Gordon-Smith K., Jones L., Fraser C., Green E. K., Grozeva D., Hamshere M. L., Holmans P. A., Jones I. R., Kirov G., Moskivina V., Nikolov I., O'Donovan M. C., Owen M. J., Collier D. A., Elkin A., Farmer A., Williamson R., McGuffin P., Young A. H., Ferrier I. N., Ball S. G., Balmforth A. J., Barrett J. H., Bishop T. D., Iles M. M., Maqbool A., Yuldasheva N., Hall A. S., Braund P. S., Dixon R. J., Mangino M., Stevens S., Thompson J. R., Bredin F., Tremelling M., Parkes M., Drummond H., Lees C. W., Nimmo E. R., Satsangi J., Fisher S. A., Forbes A., Lewis C. M., Onnie C. M., Prescott N. J., Sanderson J., Matthew C. G., Barbour J., Mohiuddin M. K., Todhunter C. E., Mansfield J. C., Ahmad T., Cummings F. R., Jewell D. P., Webster J., Brown M. J., Lathrop M. G., Connell J., Dominiczak A., Marcano C. A. B., Burke B., Dobson R., Gungadoo J., Lee K. L., Munroe P. B., Newhouse S. J., Onipinla A., Wallace C., Xue M., Caulfield M., Farrall M., Barton A., Bruce I. N., Donovan H., Eyre S., Gilbert P. D., Hilder S. L., Hinks A. M., John S. L., Potter C., Silman A. J., Symmons D. P. M., Thomson W., Worthington J., Dunger D. B., Widmer B., Frayling T. M., Freathy R. M., Lango H., Perry J. R. B., Shields B. M., Weedon M. N., Hattersley A. T., Hitman G. A., Walker M., Elliott K. S., Groves C. J., Lindgren C. M., Rayner N. W., Timpson N. J., Zeggini E., Newport M., Sirugo G., Lyons E., Vannberg F., Hill A. V. S., Bradbury L. A., Farrar C., Pointon J. J., Wordsworth P., Brown M. A., Franklyn J. A., Heward J. M., Simmonds M. J., Gough S. C. L., Seal S., Stratton M. R., Rahman N., Ban M., Goris A., Sawcer S. J., Compston A., Conway D., Jallow M., Rockett K. A., Bumpstead S. J., Chaney A., Downes K., Ghori M. J. R., Gwilliam R., Hunt S. E., Inouye M., Keniry A., King E., McGinnis R., Potter S., Ravindrarajah R., Whittaker P., Widden C., Withers D., Cardin N. J., Ferreira T., Pereira-Gale J., Hallgrimsdttir I. B., Howie B. N., Su Z., Teo Y. Y., Vukcevic D., Bentley D., Mitchell S. L., Newby P. R., Brand O. J., Carr-Smith J., Pearce S. H. S., Gough S. C. L., McGinnis R., Keniry A., Deloukas P., Reveille J. D., Zhou X., Sims A.-M., Dowling A., Taylor J., Doan T., Davis J. C., Savage L., Ward M. M., Learch T. L., Weisman M. H., Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants Nature Genetics 2007 39 11 1329 1337 (Pubitemid 350041542)
47. Aulchenko Y. S., Hoppenbrouwers I. A., Ramagopalan S. V., Broer L., Jafari N., Hillert J., Link J., Lundstrm W., Greiner E., Dessa Sadovnick A., Goossens D., Van Broeckhoven C., Del-Favero J., Ebers G. C., Oostra B. A., Van Duijn C. M., Hintzen R. Q., Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis Nature Genetics 2008 40 12 1402 1403
48. Zoledziewska M., Costa G., Pitzalis M., Cocco E., Melis C., Moi L., Zavattari P., Murru R., Lampis R., Morelli L., Poddie F., Frongia P., Pusceddu P., Bajorek M., Marras A., Satta A. M., Chessa A., Pugliatti M., Sotgiu S., Whalen M. B., Rosati G., Cucca F., Marrosu M. G., Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia Genes and Immunity 2009 10 1 15 17
49. Hoppenbrouwers I. A., Aulchenko Y. S., Janssens A. C., Ramagopalan S. V., Broer L., Kayser M., Ebers G. C., Oostra B. A., Van Duijn C. M., Hintzen R. Q., Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis Journal of Human Genetics 2009 54 11 676 680
50. Wieczorek S., Hoffjan S., Chan A., Rey L., Harper L., Fricke H., Holle J. U., Gross W. L., Epplen J. T., Lamprecht P., Novel association of the CD226 (DNAM-1) Gly307Ser polymorphism in Wegener's granulomatosis and confirmation for multiple sclerosis in German patients Genes and Immunity 2009 10 6 591 595
51. Hoppenbrouwers I. A., Aulchenko Y. S., Ebers G. C., Ramagopalan S. V., Oostra B. A., van Duijn C. M., Hintzen R. Q., EVI5 is a risk gene for multiple sclerosis Genes and Immunity 2008 9 4 334 337 (Pubitemid 351791489)
52. McCauley J. L., Hussman J. P., Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci Human Molecular Genetics 2009 19 5 953 962
53. Booth D. R., Heard R. N., Stewart G. J., Goris A., Dobosi R., Dubois B., Lorentzen. R., Celius E. G., Harbo H. F., Spurkland A., Olsson T., Kockum I., Link J., Hillert J., Ban M., Baker A., Sawcer S., Compston A., Mihalova T., Strange R., Hawkins C., Ingram G., Robertson N. P., De Jager P. L., Hafler D. A., Barcellos L. F., Ivinson A. J., Pericak-Vance M., Oksenberg J. R., Hauser S. L., McCauley J. L., Sexton D., Haines J., The expanding genetic overlap between multiple sclerosis and type I diabetes Genes and Immunity 2009 10 1 11 14
54. De Jager P. L., Jia X., Wang J., De Bakker P. I. W., Ottoboni L., Aggarwal N. T., Piccio L., Raychaudhuri S., Tran D., Aubin C., Briskin R., Romano S., Baranzini S. E., McCauley J. L., Pericak-Vance M. A., Haines J. L., Gibson R. A., Naeglin Y., Uitdehaag B., Matthews P. M., Kappos L., Polman C., McArdle W. L., Strachan D. P., Evans D., Cross A. H., Daly M. J., Compston A., Sawcer S. J., Weiner H. L., Hauser S. L., Hafler D. A., Oksenberg J. R., Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci Nature Genetics 2009 41 7 776 782
55. Egwuagu C. E., STAT3 in CD4+ T helper cell differentiation and inflammatory diseases Cytokine 2009 47 3 149 156
56. Sanna S., Pitzalis M., Zoledziewska M., Zara I., Sidore C., Murru R., Whalen M. B., Busonero F., Maschio A., Costa G., Melis M. C., Deidda F., Poddie F., Morelli L., Farina G., Li Y., Dei M., Lai S., Mulas A., Cuccuru G., Porcu E., Liang L., Zavattari P., Moi L., Deriu E., Urru M. F., Bajorek M., Satta M. A., Cocco E., Ferrigno P., Sotgiu S., Pugliatti M., Traccis S., Angius A., Melis M., Rosati G., Abecasis G. R., Uda M., Marrosu M. G., Schlessinger D., Cucca F., Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis Nature Genetics 2010 42 6 495 497
57. DeLuca G. C., Ramagopalan S. V., Herrera B. M., Dyment D. A., Lincoln M. R., Montpetit A., Pugliatti M., Barnardo M. C. N., Risch N. J., Sadovnick A. D., Chao M., Sotgiu S., Hudson T. J., Ebers G. C., An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus Proceedings of the National Academy of Sciences of the United States of America 2007 104 52 20896 20901
58. Stankovich J., Butzkueven H., Marriott M., Chapman C., Tubridy N., Tait B. D., Varney M. D., Taylor B. V., Foote S. J., Kilpatrick T. J., Rubio J. P., HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis Tissue Antigens 2009 74 1 17 21
59. Romero-Pinel L., Pujal J. M., Martinez-Yelamos S., HLA-DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population. European Journal of Neurology. In Press
60. Cournu-Rebeix I., Génin E., Leray E., Babron M.-C., Cohen J., Gout C., Alizadeh M., Perdry H., Semana G., Brassat D., Clerget-Darpoux F., Yaouanq J., Edan G., Rosenheim M., Fontaine B., HLA-DRB1 15 allele influences the later course of relapsing remitting multiple sclerosis Genes and Immunity 2008 9 6 570 574
61. Podbielska M., Hogan E. L., Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis? Multiple Sclerosis 2009 15 9 1011 1029
62. Baranzini S. E., Wang J., Gibson R. A., Galwey N., Naegelin Y., Barkhof F., Radue E.-W., Lindberg R. L. P., Uitdehaag B. M. G., Johnson M. R., Angelakopoulou A., Hall L., Richardson J. C., Prinjha R. K., Gass A., Geurts J. J. G., Kragt J., Sombekke M., Vrenken H., Qualley P., Lincoln R. R., Gomez R., Caillier S. J., George M. F., Mousavi H., Guerrero R., Okuda D. T., Cree B. A. C., Green A. J., Waubant E., Goodin D. S., Pelletier D., Matthews P. M., Hauser S. L., Kappos L., Polman C. H., Oksenberg J. R., Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis Human Molecular Genetics 2009 18 4 767 778
63. Barnett M. H., Parratt J. D., Pollard J. D., Prineas J. W., MS: is it one disease? International MS Journal 2009 16 2 57 65
64. Lassmann H., Brck W., Lucchinetti C. F., The immunopathology of multiple sclerosis: an overview Brain Pathology 2007 17 2 210 218 (Pubitemid 46466140)
65. Gay F. W., Drye T. J., Dick G. W. A., Esiri M. M., The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis: identification and characterization of the primary demyelinating lesion Brain 1997 120 8 1461 1483
66. Tzartos J. S., Friese M. A., Craner M. J., Palace J., Newcombe J., Esiri M. M., Fugger L., Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis American Journal of Pathology 2008 172 1 146 155 (Pubitemid 351186376)
67. Calabrese M., Filippi M., Gallo P., Cortical lesions in multiple sclerosis Nature Reviews Neurology 2010 6 8 438 444
68. Chard D. T., Griffin C. M., McLean M. A., Kapeller P., Kapoor R., Thompson A. J., Miller D. H., Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis Brain 2002 125 10 2342 2352
69. De Stefano N., Matthews P. M., Filippi M., Agosta F., De Luca M., Bartolozzi M. L., Guidi L., Ghezzi A., Montanari E., Cifelli A., Federico A., Smith S. M., Evidence of early cortical atrophy in MS: relevance to white matter changes and disability Neurology 2003 60 7 1157 1162 (Pubitemid 36418778)
70. Dalton C. M., Chard D. T., Davies G. R., Miszkiel K. A., Altmann D. R., Fernando K., Plant G. T., Thompson A. J., Miller D. H., Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes Brain 2004 127 5 1101 1107 (Pubitemid 38623045)
71. Kutzelnigg A., Lucchinetti C. F., Stadelmann C., Brck W., Rauschka H., Bergmann M., Schmidbauer M., Parisi J. E., Lassmann H., Cortical demyelination and diffuse white matter injury in multiple sclerosis Brain 2005 128 11 2705 2712 (Pubitemid 41552953)
72. Ozawa K., Suchanek G., Breitschopf H., Bruck W., Budka H., Jellinger K., Lassmann H., Patterns of oligodendroglia pathology in multiple sclerosis Brain 1994 117 6 1311 1322
73. Prineas J. W., Kwon E. E., Cho E.-S., Sharer L. R., Barnett M. H., Oleszak E. L., Hoffman B., Morgan B. P., Immunopathology of secondary- progressive multiple sclerosis Annals of Neurology 2001 50 5 646 657 (Pubitemid 33021923)
74. Magliozzi R., Howell O., Vora A., Serafini B., Nicholas R., Puopolo M., Reynolds R., Aloisi F., Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology Brain 2007 130 4 1089 1104 (Pubitemid 47355604)
75. Dal Bianco A., Bradl M., Frischer J., Kutzelnigg A., Jellinger K., Lassmann H., Multiple sclerosis and Alzheimer's disease Annals of Neurology 2008 63 2 174 183 (Pubitemid 351355296)
76. Franciotta D., Salvetti M., Lolli F., Serafini B., Aloisi F., B cells and multiple sclerosis The Lancet Neurology 2008 7 9 852 858
77. Serafini B., Rosicarelli B., Franciotta D., Magliozzi R., Reynolds R., Cinque P., Andreoni L., Trivedi P., Salvetti M., Faggioni A., Aloisi F., Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain Journal of Experimental Medicine 2007 204 12 2899 2912 (Pubitemid 350179559)
78. Evangelou N., DeLuca G. C., Owens T., Esiri M. M., Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions Brain 2005 128 1 29 34 (Pubitemid 40070517)
79. Esiri M. M., MS: is it one disease? International MS Journal 2009 16 2 39 41
80. Breij E. C. W., Brink B. P., Veerhuis R., Van Den Berg C., Vloet R., Yan R., Dijkstra C. D., Van Der Valk P., B L., Homogeneity of active demyelinating lesions in established multiple sclerosis Annals of Neurology 2008 63 1 16 25 (Pubitemid 351240547)
81. Barnett M. H., Prineas J. W., Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion Annals of Neurology 2004 55 4 458 468 (Pubitemid 38391962)
82. Barnett M. H., Parratt J. D. E., Cho E.-S., Prineas J. W., Immunoglobulins and complement in postmortem multiple sclerosis tissue Annals of Neurology 2009 65 1 32 46
83. B L., Vedeler C. A., Nyland H. I., Trapp B. D., Mrk S. J., Subpial demyelination in the cerebral cortex of multiple sclerosis patients Journal of Neuropathology and Experimental Neurology 2003 62 7 723 732 (Pubitemid 36870458)
84. DeLuca G. C., Ebers G. C., Esiri M. M., Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts Brain 2004 127 5 1009 1018 (Pubitemid 38623038)
85. DeLuca G. C., Williams K., Evangelou N., Ebers G. C., Esiri M. M., The contribution of demyelination to axonal loss in multiple sclerosis Brain 2006 129 6 1507 1516 (Pubitemid 43999383)
86. Zamvil S. S., Steinman L., The T lymphocyte in experimental allergic encephalomyelitis Annual Review of Immunology 1990 8 579 621 (Pubitemid 20135640)
87. Brok H. P. M., Van Meurs M., Blezer E., Schantz A., Peritt D., Treacy G., Laman J. D., Bauer J., 'T Hart B. A., Prevention of experimental autoimmune encephalomyelitis in common marmosets using an anti-IL-12p40 monoclonal antibody Journal of Immunology 2002 169 11 6554 6563 (Pubitemid 36903508)
88. Segal B. M., Constantinescu C. S., Raychaudhuri A., Kim L., Fidelus-Gort R., Kasper L. H., Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study The Lancet Neurology 2008 7 9 796 804
89. Brettschneider J., Czerwoniak A., Senel M., Fang L., Kassubek J., Pinkhardt E., Lauda F., Kapfer T., Jesse S., Lehmensiek V., Ludolph A. C., Otto M., Tumani H., The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS) PLoS ONE 2010 5 8 1 6
90. Sellebjerg F., Brnsen L., Khademi M., Krakauer M., Olsson T., Frederiksen J. L., Srensen P. S., Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS Neurology 2009 73 23 2003 2010
91. Bar-Or A., Fawaz L., Fan B., Darlington P. J., Rieger A., Ghorayeb C., Calabresi P. A., Waubant E., Hauser S. L., Zhang J., Smith C. H., Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS? Annals of Neurology 2010 67 4 452 461
92. Bar-Or A., Calabresi P. A. J., Arnold D., Markowitz C., Shafer S., Kasper L. H., Waubant E., Gazda S., Fox R. J., Panzara M., Sarkar N., Agarwal S., Smith C. H., Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase 1 trial Annals of Neurology 2008 63 6 395 400 (Pubitemid 351499869)
93. Hauser S. L., Waubant E., Arnold D. L., Vollmer T., Antel J., Fox R. J., Bar-Or A., Panzara M., Sarkar N., Agarwal S., Langer-Gould A., Smith C. H., B-cell depletion with rituximab in relapsing-remitting multiple sclerosis The New England Journal of Medicine 2008 358 7 676 688 (Pubitemid 351240747)
94. Friese M. A., Fugger L., Pathogenic CD8+ T cells in multiple sclerosis Annals of Neurology 2009 66 2 132 141
95. Junker A., Ivanidze J., Malotka J., Eiglmeier I., Lassmann H., Wekerle H., Meinl E., Hohlfeld R., Dornmair K., Multiple sclerosis: T-cell receptor expression in distinct brain regions Brain 2007 130 11 2789 2799 (Pubitemid 350033964)
96. Skulina C., Schmidt S., Dornmair K., Babbe H., Roers A., Rajewsky K., Wekerle H., Hohlfeld R., Goebels N., Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood Proceedings of the National Academy of Sciences of the United States of America 2004 101 8 2428 2433 (Pubitemid 38269328)
97. Jacobsen M., Cepok S., Quak E., Happel M., Gaber R., Ziegler A., Schock S., Oertel W. H., Sommer N., Hemmer B., Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients Brain 2002 125 3 538 550 (Pubitemid 34194409)
98. Korn T., Bettelli E., Oukka M., Kuchroo V. K., IL-17 and Th17 cells Annual Review of Immunology 2009 27 485 517
99. Dong C., TH17 cells in development: an updated view of their molecular identity and genetic programming Nature Reviews Immunology 2008 8 5 337 348 (Pubitemid 351595217)
100. Fransson M. E., Liljenfeldt L. S. E., Fagius J., Ttterman T. H., Loskog A. S. I., The T-cell pool is anergized in patients with multiple sclerosis in remission Immunology 2009 126 1 92 101
101. Brucklacher-Waldert V., Stuerner K., Kolster M., Wolthausen J., Tolosa E., Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis Brain 2009 132 12 3329 3341
102. Frisullo G., Angelucci F., Caggiula M., Nociti V., Iorio R., Patanella A. K., Sancricca C., Mirabella M., Tonali P. A., Batocchi A. P., pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity Journal of Neuroscience Research 2006 84 5 1027 1036 (Pubitemid 44521047)
103. Du C., Liu C., Kang J., Zhao G., Ye Z., Huang S., Li Z., Wu Z., Pei G., MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis Nature Immunology 2009 10 12 1252 1259
104. Viglietta V., Baecher-Allan C., Weiner H. L., Hafler D. A., Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis Journal of Experimental Medicine 2004 199 7 971 979 (Pubitemid 38481088)
105. Haas J., Hug A., Viehver A., Fritzsching B., Falk C. S., Filser A., Vetter T., Milkova L., Korporal M., Fritz B., Storch-Hagenlocher B., Krammer P. H., Suri-Payer E., Wildemann B., Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis European Journal of Immunology 2005 35 11 3343 3352 (Pubitemid 41672538)
106. Kumar M., Putzki N., Limmroth V., Remus R., Lindemann M., Knop D., Mueller N., Hardt C., Kreuzfelder E., Grosse-Wilde H., CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis Journal of Neuroimmunology 2006 180 1-2 178 184 (Pubitemid 44767710)
107. Smolders J., Menheere P., Thewissen M., Peelen E., Tervaert J. W. C., Hupperts R., Damoiseaux J., Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis Journal of Steroid Biochemistry and Molecular Biology 2010 121 1-2 243 246
108. Ascherio A., Munger K. L., Simon K. C., Vitamin D and multiple sclerosis The Lancet Neurology 2010 9 6 599 612
109. Venken K., Hellings N., Broekmans T., Hensen K., Rummens J.-L., Stinissen P., Natural naive CD4+CD25+CD127low regulatory T cell (Treg) development and
110. Haas J., Fritzsching B., Trbswetter P., Korporal M., Milkova L., Fritz B., Vobis D., Krammer P. H., Suri-Payer E., Wildemann B., Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines T reg dysfunction in multiple sclerosis Journal of Immunology 2007 179 2 1322 1330
111. Venken K., Hellings N., Liblau R., Stinissen P., Disturbed regulatory T cell homeostasis in multiple sclerosis Trends in Molecular Medicine 2010 16 2 58 68
112. Zozulya A. L., Wiendl H., The role of regulatory T cells in multiple sclerosis Nature Clinical Practice Neurology 2008 4 7 384 398 (Pubitemid 352003290)
113. Segal B. M., The role of natural killer cells in curbing neuroinflammation Journal of Neuroimmunology 2007 191 1-2 2 7 (Pubitemid 350060993)
114. De Jager P. L., Rossin E., Pyne S., Tamayo P., Ottoboni L., Viglietta V., Weiner M., Soler D., Izmailova E., Faron-Yowe L., O'Brien C., Freeman S., Granados S., Parker A., Roubenoff R., Mesirov J. P., Khoury S. J., Hafler D. A., Weiner H. L., Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells Brain 2008 131 7 1701 1711 (Pubitemid 351957464)
115. Axtell R. C., De Jong B. A., Boniface K., T helper type 1 and 17 cells determine efficacy of interferon- in multiple sclerosis and experimental encephalomyelitis Nature Medicine 2010 16 4 406 412
116. Weaver C. T., Hatton R. D., Interplay between the TH 17 and TReg cell lineages: a (co-)evolutionary perspective Nature Reviews Immunology 2009 9 12 883 889
117. Ascherio A., Munger K. L., Epstein-barr virus infection and multiple sclerosis: a review Journal of Neuroimmune Pharmacology 2010 5 3 271 277
118. Pappas D. J., Oksenberg J. R., Multiple sclerosis pharmacogenomics: maximizing efficacy of therapy Neurology 2010 74 supplement 1 S62 S69